Growth Metrics

Oculis Holding AG (OCS) Non Operating Income (2022 - 2026)

Quarterly Non Operating Income fell 569.4% to -$1.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$7.6 million through Mar 2026, up 43.98% year-over-year, with the annual reading at $5.0 million for FY2025, 263.26% up from the prior year.

Oculis Holding AG's Non Operating Income history spans 5 years, with the latest figure at -$1.1 million for Q1 2026.

  • Non Operating Income came in at -$1.1 million for Q1 2026, down from -$476695.7 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $8.6 million in Q4 2022 to a low of -$13.3 million in Q4 2024.
  • The 5-year median for Non Operating Income is -$982281.8 (2024), against an average of -$1.6 million.
  • The largest YoY upside for Non Operating Income was 182.58% in 2024 against a maximum downside of 3491.22% in 2024.
  • Oculis Holding AG's Non Operating Income stood at $8.6 million in 2022, then crashed by 104.31% to -$369772.3 in 2023, then plummeted by 3491.22% to -$13.3 million in 2024, then skyrocketed by 96.41% to -$476695.7 in 2025, then tumbled by 135.47% to -$1.1 million in 2026.
  • Per Business Quant, the three most recent readings for OCS's Non Operating Income are -$1.1 million (Q1 2026), -$476695.7 (Q4 2025), and -$393784.5 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 444,000.00
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 201.20 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn -46.98 Mn
10 Oculis Holding AG 24.51 Bn 24.21 Bn - -1.12 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.12 Mn
Dec 31, 2025 -476,695.69
Sep 30, 2025 -393,784.50
Jun 30, 2025 -5.59 Mn
Mar 31, 2025 239,133.87
Dec 31, 2024 -13.28 Mn
Sep 30, 2024 -2.36 Mn
Jun 30, 2024 1.85 Mn
Mar 31, 2024 -842,076.50
Dec 31, 2023 -369,772.27
Sep 30, 2023 -5.17 Mn
Jun 30, 2023 -2.24 Mn
Mar 31, 2023 2.19 Mn
Dec 31, 2022 8.58 Mn
Sep 30, 2022 -3.18 Mn
Jun 30, 2022 -3.18 Mn